Lexicon Pharmaceuticals, Inc. (LXRX): 5 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 27, 2026 | Debbane Raymond Director | 2,000 | $1.49 | $3.0K | no history |
| Feb 25, 2026 | Debbane Raymond Director | 100,000 | $1.47 | $147.0K | no history |
| Feb 23, 2026 | Debbane Raymond Director | 150,000 | $1.47 | $220.0K | no history |
| Feb 18, 2026 | Debbane Raymond Director | 268,497 | $1.31 | $353.1K | no history |
| Feb 4, 2026 | Artal Group S.A. Director, TenPercentOwner | 1,538,462 | $1.30 | $2.0M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.